116 related articles for article (PubMed ID: 4298614)
1. [Clinical experiences with the hemostyptic Presomen].
Volkmuth G
HNO; 1967 Apr; 15(4):123-4. PubMed ID: 4298614
[No Abstract] [Full Text] [Related]
2. [On the use of Presomen in the therapy of urogenital hemorrhages].
Rosdy E; Szabó V; Magasi P
Z Urol Nephrol; 1968 Sep; 61(9):597-601. PubMed ID: 4307119
[No Abstract] [Full Text] [Related]
3. [Hemostatic effect of conjugated estrogenic substances].
Toriyama M; Hoshino T; Sato Y
Jibiinkoka; 1967 Mar; 39(3):333-6. PubMed ID: 4294843
[No Abstract] [Full Text] [Related]
4. [Comparing investigations of two hemostyptics on patients with prostatectomy (author's transl)].
Frank W; Limbacher G
Urologe A; 1974 Jan; 13(1):27-30. PubMed ID: 4363182
[No Abstract] [Full Text] [Related]
5. [Hemostatic action of estrogens in ORL. Trials of Premarine].
Hadj-Djilani A
Rev Med Suisse Romande; 1966 Mar; 86(3):216-24. PubMed ID: 4286236
[No Abstract] [Full Text] [Related]
6. [Presomen Special administered to women after surgical removal of ovaries (author's transl)].
Houdek J; Pelák Z; Bresták M; Jezek J
Cesk Gynekol; 1974 Sep; 39(8):611-3. PubMed ID: 4373181
[No Abstract] [Full Text] [Related]
7. [Experiences with a hemostatic of estrogen basis in the tooth and jaw region].
Paatsch H
DDZ; 1966 Nov; 20(22):707-10. PubMed ID: 4288646
[No Abstract] [Full Text] [Related]
8. Conjugated estrogens for the management of gastrointestinal bleeding secondary to uremia of acute renal failure.
Heunisch C; Resnick DJ; Vitello JM; Martin SJ
Pharmacotherapy; 1998; 18(1):210-7. PubMed ID: 9469696
[TBL] [Abstract][Full Text] [Related]
9. [Use of premarin in ORL].
Mounier-Kuhn P; Bouchayer M
J Fr Otorhinolaryngol Audiophonol Chir Maxillofac (1967); 1970 Oct; 19(8):693-6. PubMed ID: 4321287
[No Abstract] [Full Text] [Related]
10. [The hemostyptic agent Altodor in otorhinopharyngology].
Broicher FJ
Munch Med Wochenschr; 1967 Oct; 109(43):2235-8. PubMed ID: 5631419
[No Abstract] [Full Text] [Related]
11. [Experiences with presomen as a physiological hemostatic in hemorrhages in the neck and nose area].
HUPPERTZ M
Ther Ggw; 1962 Jan; 101():22-5. PubMed ID: 14450106
[No Abstract] [Full Text] [Related]
12. Safety factors in dacryocystorhinostomy.
Mathur SP
Int Surg; 1967 Sep; 48(3):296-9. PubMed ID: 4291811
[No Abstract] [Full Text] [Related]
13. [Conjugated estrogens as a hemostatic in urology with special reference to their intramuscular administration].
Altieri A; Romano C
Minerva Urol; 1972; 24(6):286-95. PubMed ID: 4374651
[No Abstract] [Full Text] [Related]
14. Use of conjugated estrogens in eye diseases.
Busch S
Ann Ophthalmol; 1976 May; 8(5):549-53. PubMed ID: 180865
[TBL] [Abstract][Full Text] [Related]
15. [The effect of intravenous use of premarin for hemostasis in the operations in the field of otolaryngology].
Yamada F
Jibiinkoka; 1965 Dec; 37(12):1231-3. PubMed ID: 4287802
[No Abstract] [Full Text] [Related]
16. [On the treatment of climacteric and dysmenorrhoic symptomes with Presomen].
Bergmann G
Ther Ggw; 1968 May; 107(5):708 passim. PubMed ID: 4304793
[No Abstract] [Full Text] [Related]
17. Physiological and psychological evaluation of the estrogen deprived patient.
Bolding OT; Willcutt HC
J Med Assoc State Ala; 1969 Nov; 39(5):459-63. PubMed ID: 4390875
[No Abstract] [Full Text] [Related]
18. Treatment of bleeding in dialysis patients.
Galbusera M; Remuzzi G; Boccardo P
Semin Dial; 2009; 22(3):279-86. PubMed ID: 19573008
[TBL] [Abstract][Full Text] [Related]
19. [Use of conjugated estrogens in diabetic retinopathy].
Németh L
Klin Monbl Augenheilkd; 1969 Oct; 155(4):543-8. PubMed ID: 4315571
[No Abstract] [Full Text] [Related]
20. A study of premarin intravenous and its influence on blood loss during transurethral prostatectomy.
Gray N; Polakow ES
J Int Med Res; 1979; 7(1):96-9. PubMed ID: 217789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
